Microglia polarization by methylprednizolone acetate accelerates cuprizone induced demyelination

被引:0
|
作者
Golaleh Noorzehi
Parichehr Pasbakhsh
Maryam Borhani-Haghighi
Iraj Ragerdi Kashani
Soheila Madadi
Fatemeh Tahmasebi
Saied Nekoonam
Maryam Azizi
机构
[1] Tehran University of Medical Sciences,School of Medicine, International Campus
[2] Tehran University of Medical Sciences,Department of Anatomy, School of Medicine
来源
Journal of Molecular Histology | 2018年 / 49卷
关键词
Inflammation; Microglia; Multiple sclerosis; Demyelination; Methylprednizolone;
D O I
暂无
中图分类号
学科分类号
摘要
Glucocorticoids (GC) are known as inflammatory drugs, which are used in neuroinflammatory diseases. Unlike the classic picture, recent studies have revealed that some GC drugs exacerbate inflammatory responses in their acute and prolonged administration. Multiple sclerosis (MS) is a demyelinating inflammatory disorder, in which reactive M1 microglia phenotype play a central role. Since methylprednisolone (MP), as a synthetic GC, are commonly used by MS patients, in this study, we evaluated the effect of long-term administration of MP on microglia polarization in cuprizone (CPZ)-induced MS model. The immunostaining results showed that chronic exposure to MP in the CPZ treated mice increased the number of Iba-1 positive microglia, which significantly expressed IP10 as M1 marker than arginase as M2 marker. MP treatment induced significant amplification in the transcript levels of iNOS and TNF-α (M1-related markers) in the corpus callosum of the MS mice, whereas no change detected in the expression of IL-10 (M2-related marker) between the groups. In addition, evaluation of myelin by luxol fast blue staining and transmission electron microscopy revealed that prolonged MP administration increased demyelination in comparison to the CPZ group. In conclusion, our results show that chronic MP therapy in the CPZ-induced demyelination model of MS polarized microglia to M1 pro-inflammatory phenotype.
引用
收藏
页码:471 / 479
页数:8
相关论文
共 50 条
  • [41] Sex Differences in the Behavioural Aspects of the Cuprizone-Induced Demyelination Model in Mice
    Paton, Kelly F.
    Hong, Sheein
    Biggerstaff, Andrew
    Kivell, Bronwyn M.
    BRAIN SCIENCES, 2022, 12 (12)
  • [42] Matrix Metalloproteinases and Their Tissue Inhibitors in Cuprizone-Induced Demyelination and Remyelination of Brain White and Gray Matter
    Skuljec, Jelena
    Gudi, Viktoria
    Ulrich, Reiner
    Frichert, Konstantin
    Yildiz, Oezlem
    Pul, Refik
    Voss, Elke V.
    Wissel, Kirsten
    Baumgaertner, Wolfgang
    Stangel, Martin
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2011, 70 (09) : 758 - 769
  • [43] Huperzine-A Improved Animal Behavior in Cuprizone-Induced Mouse Model by Alleviating Demyelination and Neuroinflammation
    Zhang, Hongyu
    Wang, Danjie
    Sun, Jingxian
    Wang, Yumeng
    Wu, Shuai
    Wang, Jun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [44] Icariin enhances remyelination process after acute demyelination induced by cuprizone exposure
    Zhang, Yifan
    Yin, Linlin
    Zheng, Na
    Zhang, Li
    Liu, Jianghong
    Liang, Weixiong
    Wang, Qi
    BRAIN RESEARCH BULLETIN, 2017, 130 : 180 - 187
  • [45] Minocycline reduces remyelination by suppressing ciliary neurotrophic factor express after cuprizone-induced demyelination
    Tanaka, Tatsuhide
    Murakami, Koichi
    Bando, Yoshio
    Yoshida, Shigetaka
    JOURNAL OF NEUROCHEMISTRY, 2013, 127 (02) : 259 - 270
  • [46] Progesterone therapy induces an M1 to M2 switch in microglia phenotype and suppresses NLRP3 inflammasome in a cuprizone-induced demyelination mouse model
    Aryanpour, Roya
    Pasbakhsh, Parichehr
    Zibara, Kazem
    Namjoo, Zeinab
    Boroujeni, Fatemeh Beigi
    Shahbeigi, Saeed
    Kashani, Iraj Ragerdi
    Beyer, Cordian
    Zendehdel, Adib
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 51 : 131 - 139
  • [47] The flavonoid Baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation
    Hashimoto, Miho
    Yamamoto, Shinji
    Iwasa, Kensuke
    Yamashina, Kota
    Ishikawa, Masaki
    Maruyama, Kei
    Bosetti, Francesca
    Yoshikawa, Keisuke
    BRAIN RESEARCH BULLETIN, 2017, 135 : 47 - 52
  • [48] Sulfasalazine alters microglia phenotype by competing endogenous RNA effect of miR-136-5p and long non-coding RNA HOTAIR in cuprizone-induced demyelination
    Duan, Chenfan
    Liu, Yanzhuo
    Li, Ying
    Chen, Honglei
    Liu, Xiaoxiao
    Chen, Xuewei
    Yue, Jiang
    Zhou, Xiaoyang
    Yang, Jing
    BIOCHEMICAL PHARMACOLOGY, 2018, 155 : 110 - 123
  • [49] Protective and therapeutic role of Bilobalide in cuprizone-induced demyelination
    Sui, Ruo-Xuan
    Miao, Qiang
    Wang, Jing
    Wang, Qing
    Song, Li-Juan
    Yu, Jing-Wen
    Cao, Liang
    Xiao, Wei
    Xiao, Bao-Guo
    Ma, Cun-Gen
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 66 : 69 - 81
  • [50] Therapeutic potential of pranlukast against cuprizone-induced inflammatory demyelination and sensory impairment in mice: Comparison with fingolimod
    Pires, Greice Nascimento
    Laurindo, Renata Pereira
    Heringer, Luiza Dos Santos
    da Silva, Stefanny Calixto
    Portela, Debora Magalhaes
    Cardoso, Ricardo
    de Padua, Ana Carolina
    De Sa, Ana Beatriz Miranda
    Da Cruz, Saulo Augusto Alves
    Araujo, Sheila Espirito Santo
    Martinez, Ana Maria Blanco
    Carneiro, Milena Batista
    Mendonca, Henrique Rocha
    NEUROTOXICOLOGY, 2025, 107 : 37 - 52